These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 21704538

  • 1. Urothelial carcinoma at the uretero-enteric junction: multi-center evaluation of oncologic outcomes after radical nephroureterectomy.
    Youssef RF, Shariat SF, Lotan Y, Cost N, Wood CG, Sagalowsky AI, Zigeuner R, Langner C, Chromecki TF, Montorsi F, Bolenz C, Margulis V.
    Urol Oncol; 2013 Jul; 31(5):676-81. PubMed ID: 21704538
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [Abstract] [Full Text] [Related]

  • 3. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J, Kikuchi E, Tanaka N, Matsumoto K, Hayakawa N, Ide H, Miyajima A, Nakagawa K, Oya M.
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [Abstract] [Full Text] [Related]

  • 4. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V.
    Eur Urol; 2012 Apr; 61(4):818-25. PubMed ID: 22284969
    [Abstract] [Full Text] [Related]

  • 5. Comparative analysis of oncologic outcomes of partial ureterectomy vs radical nephroureterectomy in upper tract urothelial carcinoma.
    Bagrodia A, Kuehhas FE, Gayed BA, Wood CG, Raman JD, Kapur P, Derweesh IH, Bensalah K, Sagalowsky AI, Shariat SF, Lotan Y, Margulis V.
    Urology; 2013 May; 81(5):972-7. PubMed ID: 23523292
    [Abstract] [Full Text] [Related]

  • 6. Macroscopic sessile tumor architecture is a pathologic feature of biologically aggressive upper tract urothelial carcinoma.
    Fritsche HM, Novara G, Burger M, Gupta A, Matsumoto K, Kassouf W, Sircar K, Zattoni F, Walton T, Tritschler S, Baba S, Bastian PJ, Martínez-Salamanca JI, Seitz C, Otto W, Wieland WF, Karakiewicz PI, Ficarra V, Hartmann A, Shariat SF.
    Urol Oncol; 2012 Sep; 30(5):666-72. PubMed ID: 20933445
    [Abstract] [Full Text] [Related]

  • 7. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy.
    Raman JD, Lin YK, Kaag M, Atkinson T, Crispen P, Wille M, Smith N, Hockenberry M, Guzzo T, Peyronnet B, Bensalah K, Simhan J, Kutikov A, Cha E, Herman M, Scherr D, Shariat SF, Boorjian SA.
    Urol Oncol; 2014 Jan; 32(1):47.e9-14. PubMed ID: 24140248
    [Abstract] [Full Text] [Related]

  • 8. The impact of previous ureteroscopic tumor ablation on oncologic outcomes after radical nephrouretectomy for upper urinary tract urothelial carcinoma.
    Gurbuz C, Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V.
    J Endourol; 2011 May; 25(5):775-9. PubMed ID: 21388245
    [Abstract] [Full Text] [Related]

  • 9. Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy?
    Youssef RF, Lotan Y, Sagalowsky AI, Shariat SF, Wood CG, Raman JD, Langner C, Zigeuner R, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V.
    Int Braz J Urol; 2013 May; 39(5):614-21. PubMed ID: 24267122
    [Abstract] [Full Text] [Related]

  • 10. The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.
    Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Hayakawa N, Kosaka T, Oyama M, Miyajima A, Momma T, Nakagawa K, Jinzaki M, Nakajima Y, Oya M.
    Urol Oncol; 2014 Jan; 32(1):48.e19-26. PubMed ID: 24055429
    [Abstract] [Full Text] [Related]

  • 11. Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.
    Espiritu PN, Sverrisson EF, Sexton WJ, Pow-Sang JM, Poch MA, Dhillon J, Spiess PE.
    Urol Oncol; 2014 Jul; 32(5):619-24. PubMed ID: 24495448
    [Abstract] [Full Text] [Related]

  • 12. Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.
    Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS.
    Urol Oncol; 2013 Nov; 31(8):1643-9. PubMed ID: 22591745
    [Abstract] [Full Text] [Related]

  • 13. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Rouprêt M, French Collaborative National Database on U.U.T.-U.C.
    BJU Int; 2012 Oct; 110(8):1134-41. PubMed ID: 22394612
    [Abstract] [Full Text] [Related]

  • 14. Prognostic relevance of postoperative platelet count in upper tract urothelial carcinoma after radical nephroureterectomy.
    Gakis G, Fritsche HM, Hassan F, Kluth L, Miller F, Soave A, Otto W, Schwentner C, Todenhöfer T, Dahlem R, Burger M, Fisch M, Stenzl A, Aziz A, Rink M.
    Eur J Cancer; 2014 Oct; 50(15):2583-91. PubMed ID: 25088206
    [Abstract] [Full Text] [Related]

  • 15. Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Pignot G, Colin P, Zerbib M, Audenet F, Soulié M, Hurel S, Delage F, Irani J, Descazeaud A, Droupy S, Rozet F, Phé V, Ruffion A, Long JA, Crouzet S, Houlgatte A, Bigot P, Guy L, Faïs PO, Rouprêt M, French Collaborative National Database on UUT-UC.
    Urol Oncol; 2014 Jan; 32(1):23.e1-8. PubMed ID: 23403206
    [Abstract] [Full Text] [Related]

  • 16. Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature.
    Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Khalil D, Kapur P, Shariat SF, Raj GV, Sagalowsky AI, Cadeddu JA, Lotan Y, Margulis V.
    Urol Oncol; 2014 Jan; 32(1):54.e19-26. PubMed ID: 24360665
    [Abstract] [Full Text] [Related]

  • 17. Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.
    Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF, Upper Tract Urothelial Carcinoma Collaboration.
    Eur Urol; 2014 Jan; 65(1):210-7. PubMed ID: 22579047
    [Abstract] [Full Text] [Related]

  • 18. A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Miyazaki Y, Kobayashi H, Kaneko G, Hagiwara M, Ide H, Obata J, Hoshino K, Hayakawa N, Kosaka T, Hara S, Oyama M, Momma T, Nakajima Y, Jinzaki M, Oya M.
    Ann Surg Oncol; 2014 Nov; 21(12):4041-8. PubMed ID: 24912614
    [Abstract] [Full Text] [Related]

  • 19. Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Rink M, Sharifi N, Fritsche HM, Aziz A, Miller F, Kluth LA, Ngamsri T, Dahlem R, Chun FK, Shariat SF, Stenzl A, Fisch M, Gakis G.
    J Urol; 2014 Feb; 191(2):316-22. PubMed ID: 24036235
    [Abstract] [Full Text] [Related]

  • 20. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M, Xylinas E, Kluth L, Trinh QD, Lee RK, Fajkovic H, Novara G, Margulis V, Lotan Y, Martinez-Salamanca JI, Matsumoto K, Seitz C, Remzi M, Karakiewicz PI, Scherr DS, Briganti A, Kautzky-Willer A, Bachmann A, Shariat SF, UTUC Collaboration.
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.